Showing 121 - 140 of 506 results
ANSTO will be participating in a new Industrial Transformation Training Centre established and funded by the Australia Research Council to advance the use of bioactive ingredients in Australia.
Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron neutron capture therapy, a promising radiation therapy for treating aggressive cancers.
International collaboration uses Australian Synchrotron on pioneering malaria research.
Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.
On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.
Project focuses on enhancing crop productivity in Asia Pacific countries by improving soil and water.
Combining resources and expertise to address climate change in the Asia-Pacific
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Deuteration and nuclear techniques can contribute to the science of beauty.
The ANSTO Science Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.
Melbourne researchers map the structure of a key COVID-19 protein using the Australian Synchrotron
Researchers from Murdoch University and associated collaborators are using ANSTO’s unique nuclear capabilities to gain detailed information about how wheat crops take in administered micronutrients to maximise their efficient use.
ANSTO is one of Australia’s largest public research organisations and is widely recognised as an international player in the field of nuclear science and technology.
The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.
X-ray crystallography at the Australian Synchrotron contributed to major research findings.
Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it. Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.